Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs NATCO PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ELDER PHARMA NATCO PHARMA ELDER PHARMA/
NATCO PHARMA
 
P/E (TTM) x -1.0 13.3 - View Chart
P/BV x 0.1 3.5 2.9% View Chart
Dividend Yield % 0.0 0.6 -  

Financials

 ELDER PHARMA   NATCO PHARMA
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
NATCO PHARMA
Mar-23
ELDER PHARMA/
NATCO PHARMA
5-Yr Chart
Click to enlarge
High Rs380847 44.9%   
Low Rs188502 37.5%   
Sales per share (Unadj.) Rs489.2148.4 329.7%  
Earnings per share (Unadj.) Rs-3.239.2 -8.1%  
Cash flow per share (Unadj.) Rs14.448.2 29.9%  
Dividends per share (Unadj.) Rs05.50 0.0%  
Avg Dividend yield %00.8 0.0%  
Book value per share (Unadj.) Rs376.5267.1 141.0%  
Shares outstanding (eoy) m20.54182.47 11.3%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.64.5 12.8%   
Avg P/E ratio x-89.317.2 -519.1%  
P/CF ratio (eoy) x19.714.0 140.8%  
Price / Book Value ratio x0.82.5 29.9%  
Dividend payout %014.0 -0.0%   
Avg Mkt Cap Rs m5,832123,049 4.7%   
No. of employees `000NANA-   
Total wages/salary Rs m2,1794,867 44.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m10,04827,071 37.1%  
Other income Rs m2571,285 20.0%   
Total revenues Rs m10,30528,356 36.3%   
Gross profit Rs m2,9219,117 32.0%  
Depreciation Rs m3611,638 22.1%   
Interest Rs m2,756145 1,900.9%   
Profit before tax Rs m608,619 0.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1251,466 8.5%   
Profit after tax Rs m-657,153 -0.9%  
Gross profit margin %29.133.7 86.3%  
Effective tax rate %209.117.0 1,229.5%   
Net profit margin %-0.626.4 -2.5%  
BALANCE SHEET DATA
Current assets Rs m9,24030,003 30.8%   
Current liabilities Rs m9,9986,831 146.4%   
Net working cap to sales %-7.585.6 -8.8%  
Current ratio x0.94.4 21.0%  
Inventory Days Days12863 202.0%  
Debtors Days Days602115 521.4%  
Net fixed assets Rs m13,64226,571 51.3%   
Share capital Rs m206365 56.3%   
"Free" reserves Rs m7,52848,373 15.6%   
Net worth Rs m7,73348,738 15.9%   
Long term debt Rs m4,8890-   
Total assets Rs m22,88256,574 40.4%  
Interest coverage x1.060.4 1.7%   
Debt to equity ratio x0.60-  
Sales to assets ratio x0.40.5 91.8%   
Return on assets %11.812.9 91.2%  
Return on equity %-0.814.7 -5.8%  
Return on capital %22.318.0 124.1%  
Exports to sales %3.10-   
Imports to sales %0.410.2 4.2%   
Exports (fob) Rs m307NA-   
Imports (cif) Rs m432,772 1.6%   
Fx inflow Rs m30717,256 1.8%   
Fx outflow Rs m1252,772 4.5%   
Net fx Rs m18114,484 1.3%   
CASH FLOW
From Operations Rs m11,7548,491 138.4%  
From Investments Rs m-561-4,771 11.7%  
From Financial Activity Rs m-6,762-3,630 186.3%  
Net Cashflow Rs m5,466208 2,627.9%  

Share Holding

Indian Promoters % 25.3 49.7 51.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 24.0 25.0 96.0%  
FIIs % 0.0 13.7 -  
ADR/GDR % 0.0 0.0 -  
Free float % 74.7 50.3 148.5%  
Shareholders   31,548 207,571 15.2%  
Pledged promoter(s) holding % 77.6 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ELDER PHARMA With:   SUN PHARMA    CIPLA    DIVIS LABORATORIES    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Elder Pharma vs Natco Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Elder Pharma vs Natco Pharma Share Price Performance

Period Elder Pharma Natco Pharma S&P BSE HEALTHCARE
1-Day 4.97% -2.11% 1.18%
1-Month 21.21% -3.19% -0.75%
1-Year -64.54% 72.80% 61.82%
3-Year CAGR -51.65% 4.96% 18.16%
5-Year CAGR -37.46% 10.96% 19.79%

* Compound Annual Growth Rate

Here are more details on the Elder Pharma share price and the Natco Pharma share price.

Moving on to shareholding structures...

The promoters of Elder Pharma hold a 25.3% stake in the company. In case of Natco Pharma the stake stands at 49.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Elder Pharma and the shareholding pattern of Natco Pharma.

Finally, a word on dividends...

In the most recent financial year, Elder Pharma paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

Natco Pharma paid Rs 5.5, and its dividend payout ratio stood at 14.0%.

You may visit here to review the dividend history of Elder Pharma, and the dividend history of Natco Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.